All Guidance
NHS England has advised CCGs that a prescription for the treatment of infrequent constipation should not routinely be offered in primary care as the condition is appropriate for self-care. The NHS England guidance applies to short term, infrequent constipation caused by changes in lifestyle or diet such as lack of water or movement or changes in diet. GPs should continue to prescribe laxatives to manage acute constipation with more complex aetiology (e.g. iatrogenic) and chronic constipation.
The NHS England guidance does not apply to the management of children and laxatives for children should continue to be prescribed by GPs.
Advanced hormone-dependent prostate cancer with spinal metastases - to be read in conjunction with the SPC
To be read in conjunction with the SPC , NICE TA 217 and NICE CG42
Denosumab 60mg injection - Treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture and treatment of bone loss
associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture
Denosumab as a second-line treatment option for the prevention of Osteoporotic Fragility Fractures
The Lancashire Medicines Management Group does not recommend the prescribing of e-Cigarettes
This guidance includes a flow chart indicating a step-wise approach to the management of ED, with additional treatment notes that have been developed to guide prescribers
Where a proprietary biological medicine is indicated and biologically similar (biosimilar) medicine(s) to the reference product also exist the product with the lowest acquisition price should be used and charged to the commissioning organisation at the acquisition price (within licensed indications).
Product choices, including changes to treatment, for individual patients should be made following assessment by the responsible clinician taking into account patient choice.
LSCMMG has granted interim approval for this position statement ONLY. LSCMMG is aware that each locality, prior to the establishment of the ICB, had adopted the 'Over the counter items that should not be routinely prescribed in primary care policy'.
Interim approval has been granted to provide consistency of advice to prescribers whilst the ICB considers whether to adopt the 'Over the counter items that should not be routinely prescribed in primary care policy' across Lancashire and South Cumbria.
**This Guideline is currently under review. For further information please click here**
Formerly the 'North West Headache Management Guideline for Adults'
To be read in conjunction with the LSCMMG guideline ‘Assessing suitability of strong opioid use’
The purpose of this guideline is to assist primary care practitioners to advise patients of the appropriate monitoring regimen for their clinical condition and diabetes type and to ensure appropriate volumes of testing strips are supplied.